Skip to main content

Cepheid to Install 300 More Anthrax-Detection Modules for US Mail Processing Centers

NEW YORK, Jan. 25 (GenomeWeb News) - Cepheid has received an order for 300 additional anthrax detection modules, to be used at mail processing centers of the United States Postal Service, the Sunnyvale, Calif.-based company said today.

 

The modules, based on Cepheid's GeneXpert PCR technology, will be used with Biohazard Detection Systems developed by Northrop Grumman's Security Systems to detect biological threats for the USPS. The new order is part of the second phase of the project, with modules being installed starting in April. At present, the company is shipping and installing 800 GeneXpert modules that were ordered for the first phase of the project.

 

Cepheid expects an additional order of 300 modules later this year. In total, detection systems are planned for 283 mail processing centers throughout the US.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.